Lee Kelley
Psychiatry · Phoenix, AZNPI 1003868647
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by AbbVie at 47.6% of the total.
Across 43 payments — averaging $34.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$710
- Takeda Pharmaceuticals U.S.A., Inc.$168
- Corium, LLC$137
- Johnson & Johnson$117
- Otsuka America Pharmaceutical, Inc.$116
- Bausch Health US, LLC$115
- plus $129 from 3 others
Across 50 payments — averaging $6824.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$194K
- Takeda Pharmaceuticals U.S.A., Inc.$58K
- AbbVie$22K
- Acadia Pharmaceuticals Inc$17K
- Avanir Pharmaceuticals, Inc.$14K
- Bristol Myers Squibb$12K
- plus $25K from 4 others
What the payments were for
- Food & beverage$1,45598%
- Education$372%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $710 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $168 |
| Corium, LLC | 2 | $137 |
| Johnson & Johnson | 1 | $117 |
| Otsuka America Pharmaceutical, Inc. | 1 | $116 |
| Bausch Health US, LLC | 7 | $115 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $83 |
| Tris Pharma Inc | 1 | $30 |
| Lundbeck LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,492 in reported general payments places this provider in the 80th percentile of 573 psychiatry providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 17 | $952 |
| Duloxetine Hcl | 25 | $808 |
| Bupropion XlBupropion Hcl | 25 | $499 |
| Escitalopram Oxalate | 15 | $342 |
| Bupropion Hcl SrBupropion Hcl | 19 | $284 |
| Mirtazapine | 13 | $249 |
| Lamotrigine | 12 | $208 |
| Propranolol Hcl | 14 | $186 |
| Zolpidem Tartrate | 13 | $149 |
| Trazodone Hcl | 14 | $98 |
| Lithium Carbonate | 12 | $85 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Phoenix
- Jason CaplanPhoenix$999K
- Thomas GazdaPhoenix$714K
- Monica BenavidezPhoenix$435K
- Eric ReimanPhoenix$157K
- Padma AkingPhoenix$44K
- Ahmed ElmaadawiPhoenix$32K
- Amnon KahanePhoenix$18K
- Aaron ClayPhoenix$14K
- Joel ParkerPhoenix$11K
- Ivan EngelPhoenix$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.